Combo-PEP: Multipurpose Prevention of Post-Exposure Prophylaxis Regimens
Condition(s):Sexually Transmitted DiseasesLast Updated:May 23, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Sexually Transmitted DiseasesLast Updated:May 23, 2023Completed
Condition(s):HIV-1-infectionLast Updated:February 28, 2024Recruiting
Condition(s):Bone LossLast Updated:April 7, 2023Recruiting
Condition(s):Harm Reduction; HIV Infections; Drug UseLast Updated:March 13, 2024Completed
Condition(s):HIV-1-infectionLast Updated:March 5, 2024Completed
Condition(s):HIV-1-infectionLast Updated:June 5, 2023Active, not recruiting
Condition(s):HivLast Updated:April 10, 2023Recruiting
Condition(s):HIV-1-infectionLast Updated:March 1, 2024Recruiting
Condition(s):HIV InfectionsLast Updated:August 30, 2023Active, not recruiting
Condition(s):Hiv; TransgenderismLast Updated:March 26, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.